Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00501449 · ClinicalTrials.gov registry record
Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
A clinical trial of Multiple Endocrine Neoplasia, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 133
- Enrollment target
- 1
- Study location
NCT00501449: Completed study of Multiple Endocrine Neoplasia, sponsored by M.D. Anderson Cancer Center.
NCT00501449 is a study of Multiple Endocrine Neoplasia that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 133 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00501449, a study of Multiple Endocrine Neoplasia, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aims of the study include: 1. Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2. 2. Evaluate MEN-specific distress as well as adherence to surveillance regimens among adults with MEN1 or MEN2, and identify associated with those outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2007-05 |
| Est. Completion | 2020-09-22 |
What the finished NCT00501449 record still lists
NCT00501449 is an observational study that tracks outcomes without assigning an intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Multiple Endocrine Neoplasia appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00501449 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00501449 about?
NCT00501449 is a clinical study titled "Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes". The specific aims of the study include: 1. Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2. 2. Evaluate MEN-specific distress as well as adherence to surveillance regimens among adults with MEN1 or MEN2, and identify associated with t...
What is the current status of trial NCT00501449?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2007-05. Estimated completion is 2020-09-22.
What conditions does trial NCT00501449 study?
This clinical trial studies the following conditions: Multiple Endocrine Neoplasia.
What interventions are being tested in trial NCT00501449?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00501449?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00501449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Endocrine Neoplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia